BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 9855538)

  • 1. Inclusion body myositis: abnormal protein accumulation does not trigger apoptosis.
    Hutchinson DO
    Neurology; 1998 Dec; 51(6):1742-5. PubMed ID: 9855538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inclusion body myositis, muscle blood vessel and cardiac amyloidosis, and transthyretin Val122Ile allele.
    Askanas V; Engel WK; Alvarez RB; Frangione B; Ghiso J; Vidal R
    Ann Neurol; 2000 Apr; 47(4):544-9. PubMed ID: 10762172
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Bcl-2 in inclusion body myositis.
    Fyhr IM; Lindberg C; Oldfors A
    Acta Neurol Scand; 2002 May; 105(5):403-7. PubMed ID: 11982494
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell death in denervated skeletal muscle is distinct from classical apoptosis.
    Borisov AB; Carlson BM
    Anat Rec; 2000 Mar; 258(3):305-18. PubMed ID: 10705351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Idiopathic inflammatory myopathies: inclusion-body myositis, polymyositis, and dermatomyositis.
    Askanas V; Engel WK; Mirabella M
    Curr Opin Neurol; 1994 Oct; 7(5):448-56. PubMed ID: 7804466
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Beta-amyloid peptide expression is sufficient for myotube death: implications for human inclusion body myopathy.
    Querfurth HW; Suhara T; Rosen KM; McPhie DL; Fujio Y; Tejada G; Neve RL; Adelman LS; Walsh K
    Mol Cell Neurosci; 2001 May; 17(5):793-810. PubMed ID: 11358479
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoclonal antibody analysis of mononuclear cells in myopathies. II: Phenotypes of autoinvasive cells in polymyositis and inclusion body myositis.
    Engel AG; Arahata K
    Ann Neurol; 1984 Aug; 16(2):209-15. PubMed ID: 6089646
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Spectrum of inclusion body myositis.
    Ringel SP; Kenny CE; Neville HE; Giorno R; Carry MR
    Arch Neurol; 1987 Nov; 44(11):1154-7. PubMed ID: 2823752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Apoptotic muscle fiber degeneration in distal myopathy with rimmed vacuoles.
    Yan C; Ikezoe K; Nonaka I
    Acta Neuropathol; 2001 Jan; 101(1):9-16. PubMed ID: 11194945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ubiquitin expression in inclusion body myositis. An immunohistochemical study.
    Albrecht S; Bilbao JM
    Arch Pathol Lab Med; 1993 Aug; 117(8):789-93. PubMed ID: 8393651
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal accumulation of prion protein mRNA in muscle fibers of patients with sporadic inclusion-body myositis and hereditary inclusion-body myopathy.
    Sarkozi E; Askanas V; Engel WK
    Am J Pathol; 1994 Dec; 145(6):1280-4. PubMed ID: 7992832
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Monoclonal antibody analysis of mononuclear cells in myopathies. I: Quantitation of subsets according to diagnosis and sites of accumulation and demonstration and counts of muscle fibers invaded by T cells.
    Arahata K; Engel AG
    Ann Neurol; 1984 Aug; 16(2):193-208. PubMed ID: 6383191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MHC class I-mediated cytotoxicity does not induce apoptosis in muscle fibers nor in inflammatory T cells: studies in patients with polymyositis, dermatomyositis, and inclusion body myositis.
    Schneider C; Gold R; Dalakas MC; Schmied M; Lassmann H; Toyka KV; Hartung HP
    J Neuropathol Exp Neurol; 1996 Dec; 55(12):1205-9. PubMed ID: 8957443
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Infiltrating polymorphonuclear leukocytes and apoptotic bodies derived from hepatocytes but not from ballooning hepatocytes containing Mallory bodies show nuclear DNA fragmentation in alcoholic hepatitis.
    Takahashi T; So-Wan T; Kamimura T; Asakura H
    Alcohol Clin Exp Res; 2000 Apr; 24(4 Suppl):68S-73S. PubMed ID: 10803784
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Inclusion body myositis and neuromuscular diseases with rimmed vacuoles].
    Figarella-Branger D; Pellissier JF; Pouget J; Calore EE; Azulay JP; Desnuelle C; Serratrice G
    Rev Neurol (Paris); 1992; 148(4):281-90. PubMed ID: 1332175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New advances in inclusion-body myositis.
    Askanas V; Engel WK
    Curr Opin Rheumatol; 1993 Nov; 5(6):732-41. PubMed ID: 8117535
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Molecular immunology and genetics of inflammatory muscle diseases.
    Dalakas MC
    Arch Neurol; 1998 Dec; 55(12):1509-12. PubMed ID: 9865793
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel immunolocalization of alpha-synuclein in human muscle of inclusion-body myositis, regenerating and necrotic muscle fibers, and at neuromuscular junctions.
    Askanas V; Engel WK; Alvarez RB; McFerrin J; Broccolini A
    J Neuropathol Exp Neurol; 2000 Jul; 59(7):592-8. PubMed ID: 10901230
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mitochondrial DNA deletions in muscle fibers in inclusion body myositis.
    Oldfors A; Moslemi AR; Fyhr IM; Holme E; Larsson NG; Lindberg C
    J Neuropathol Exp Neurol; 1995 Jul; 54(4):581-7. PubMed ID: 7602331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential expression of chemokines in inflammatory myopathies.
    De Bleecker JL; De Paepe B; Vanwalleghem IE; Schröder JM
    Neurology; 2002 Jun; 58(12):1779-85. PubMed ID: 12084877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.